Home » Products » Generic Pharmaceutical Drugs » Daclizymab Injection

Daclizymab Injection

Daclizymab Injection
Daclizymab Injection
Send Inquiry
Product Code : 34
Price And Quantity
  • Minimum Order Quantity
  • 10
  • Unit of Measure
  • Box/Boxes
  • Price
  • 2500 INR
Product Description
Daclizymab Injection is an immunosuppressive, humanized IgG1 monoclonal antibody produced by recombinant DNA technology that binds specifically to the alpha subunit (P55 alpha, CD25, or Tac subunit) of the human high-affinity interleukin-2 (IL-2) receptor that is expressed on the surface of activated lymphocytes.

Daclizumab is a composite of human (90%) and murine (10%) antibody sequences. The human sequences were derived from the constant domains of human IgG1 and the variable framework regions of the Eu myeloma antibody. The murine sequences were derived from the complementarity-determining regions of a murine anti-Tac antibody. The molecular weight predicted from the DNA sequence is 144 kilodaltons.
Trade Information
  • Payment Terms
  • Cheque, Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 100 Per Week
  • Delivery Time
  • 5 Days
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • Main Domestic Market
  • All India

3S CORPORATION
X


Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.